64-Slice CT System Has Wide Aperture and Lateral Shifting Table

Hitachi Medical Systems America, Inc. (Twinsburg, OH, USA), a provider of diagnostic imaging equipment, announced US Food and Drug Administration (FDA) clearance to market its Scenaria CT system, the latest in the company's line of CT products.

"Scenaria is another example of Hitachi's ability to provide a superior product by combining the latest dose saving and imaging technologies with unparalleled ergonomic benefits afforded by a slimmer gantry design with wider 75-cm aperture and a lateral shifting table,” said Mark Silverman, manager of CT marketing. "Scenaria includes a complete suite of dose reduction and awareness features, including Intelli IP iterative reconstruction, to enable high-quality lower dose scanning across the full range of applications for adult and pediatric patients.”

"With more than 68 million CT procedures ordered across the US in 2009, it is important for CT to continue to achieve the good benefits of its diagnostic potential while further reducing patient radiation risk. Scenaria, with its array of prescient technologies is an important tool for enhancing these benefits and reducing the radiation risk of CT exams,” said Sheldon Schaffer, vice president and general manager, MR and CT.

Related Links:
Hitachi Medical Systems America